Ownership history in FreeGulliver LLC · 7 quarters on record
This page tracks every 13F SEC filing in which FreeGulliver LLC reported a position in THE ONCOLOGY INSTITUTE INC (TOI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 355,672 | +145,672 | +69.4% | 0.47% | $1.3M | $3.56 |
| 2025 Q3 | REDUCED | 210,000 | -133,800 | -38.9% | 0.33% | $733K | $3.49 |
| 2025 Q2 | REDUCED | 343,800 | -200,561 | -36.8% | 0.32% | $705K | $2.05 |
| 2025 Q1 | REDUCED | 544,361 | -56,386 | -9.4% | 0.31% | $621K | $1.14 |
| 2024 Q4 | ADDED | 600,747 | +412,578 | +219.3% | 0.09% | $186K | $0.31 |
| 2024 Q3 | ADDED | 188,169 | +123,169 | +189.5% | 0.04% | $62K | $0.33 |
| 2024 Q2 | INITIATED | 65,000 | — | — | 0.18% | $133K | — |
As of 2025 Q4 — sorted by position size